Role of Evaluating MGMT Status and 1p36 Deletion in Radiosurgery-Induced Anaplastic Ependymoma That Rapidly and Completely Resolved by Temozolomide Alone: Case Report and Review of the Literature

Abstract

Stereotactic gamma knife surgery (GKS)-induced brain tumors are extremely rare, and no ependymal tumors induced by GKS have been reported. Therefore, little is known about their clinical, pathologic, and genetic features. In addition, a regimen of adjuvant chemotherapy for anaplastic ependymoma (AE) has not been established. A 77-year-old man presented with a gait disturbance and left-side cerebellar ataxia more than 19 years after GKS performed for a cerebellar arteriovenous malformation. Imaging studies demonstrated an enhancing mass in the irradiated field with signs of intraventricular dissemination. Surgical resection confirmed the diagnosis of AE. Temozolomide (TMZ) was administrated postoperatively because the methylated promoter region of O⁶-methylguanine-DNA methyltransferase (MGMT) and 1p36 deletion were observed. Surprisingly, images 16 days after TMZ initiation demonstrated a complete resolution of the residual tumor that was maintained after three cycles of TMZ. This first case report of GKS-induced AE emphasizes the importance of genetic evaluation of MGMT and chromosomal deletion of 1p36 that are not commonly performed in primary ependymal tumors. In addition, it is speculated that a GKS-induced tumor may have a different genetic background compared with the primary tumor because the pathogenesis of the tumors differed.

Keywords

anaplastic ependymoma - radiosurgery - MGMT - 1p36 - temozolomide

• References

• 1 Yu JS, Yong WH, Wilson D, Black KL. Glioblastoma induction after radiosurgery for meningioma. Lancet 2000; 356 (9241) 1576-1577
• 2 Kaido T, Hoshida T, Uranishi R , et al. Radiosurgery-induced brain tumor. Case report. J Neurosurg 2001; 95 (4) 710-713
• 3 Shamisa A, Bance M, Nag S , et al. Glioblastoma multiforme occurring in a patient treated with gamma knife surgery. Case report and review of the literature. J Neurosurg 2001; 94 (5) 816-821
• 4 McIver JI, Pollock BE. Radiation-induced tumor after stereotactic radiosurgery and whole brain radiotherapy: case report and literature review. J Neurooncol 2004; 66 (3) 301-305
• 5 Sheehan J, Yen CP, Steiner L. Gamma knife surgery-induced meningioma. Report of two cases and review of the literature. J Neurosurg 2006; 105 (2) 325-329
• 6 Berman EL, Eade TN, Brown D , et al. Radiation-induced tumor after stereotactic radiosurgery for an arteriovenous malformation: case report. Neurosurgery 2007; 61 (5) E1099; discussion E1099
• 7 Starke RM, Yen CP, Chen CJ , et al. An updated assessment of the risk of radiation-induced neoplasia after radiosurgery of arteriovenous malformations. World Neurosurg 2014; 82 (3-4) 395-401
• 8 Cahan WG, Woodard HQ, Higinbotham NL, Steward FW, Coley BL. Sarcoma arising in irradiated bone: report of eleven cases. 1948. Cancer 1998; 82 (1) 8-34
• 9 Haselow RE, Nesbit M, Dehner LP, Khan FM, McHugh R, Levitt SH. Second neoplasms following megavoltage radiation in a pediatric population. Cancer 1978; 42 (3) 1185-1191
• 10 Anderson JR, Treip CS. Radiation-induced intracranial neoplasms. A report of three possible cases. Cancer 1984; 53 (3) 426-429
• 11 Khoo HM, Kishima H, Kinoshita M , et al. Radiation-induced anaplastic ependymoma with a remarkable clinical response to temozolomide: a case report. Br J Neurosurg 2013; 27 (2) 259-261
• 12 Rowe J, Grainger A, Walton L, Silcocks P, Radatz M, Kemeny A. Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery 2007; 60 (1) 60-65 ; discussion 65–66
• 13 Hegi ME, Diserens AC, Gorlia T , et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352 (10) 997-1003
• 14 Koos B, Peetz-Dienhart S, Riesmeier B, Frühwald MC, Hasselblatt M. O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation is significantly less frequent in ependymal tumours as compared to malignant astrocytic gliomas. Neuropathol Appl Neurobiol 2010; 36 (4) 356-358
• 15 Alentorn A, Sanson M, Idbaih A. Oligodendrogliomas: new insights from the genetics and perspectives. Curr Opin Oncol 2012; 24 (6) 687-693
• 16 Zheng PP, Pang JC, Hui AB, Ng HK. Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas. Cancer Genet Cytogenet 2000; 122 (1) 18-25